NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 51 filers reported holding NEUBASE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $25 | +31.6% | 132,500 | +33.8% | 0.02% | +20.0% |
| Q4 2022 | $19 | -100.0% | 99,000 | +1.0% | 0.02% | -54.5% |
| Q3 2022 | $39,000 | -54.7% | 98,000 | +20.2% | 0.04% | -50.6% |
| Q2 2022 | $86,000 | -31.2% | 81,500 | +22.6% | 0.09% | -12.7% |
| Q1 2022 | $125,000 | +48.8% | 66,500 | +121.7% | 0.10% | +78.9% |
| Q4 2021 | $84,000 | +10.5% | 30,000 | +42.9% | 0.06% | +21.3% |
| Q3 2021 | $76,000 | +7.0% | 21,000 | +41.9% | 0.05% | +17.5% |
| Q2 2021 | $71,000 | – | 14,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $494,000 | 0.50% |
| CARNEGIE MELLON UNIVERSITY | 939,412 | $986,000 | 0.50% |
| CM Management, LLC | 370,000 | $389,000 | 0.41% |
| Decheng Capital Management III (Cayman), LLC | 1,000,000 | $1,050,000 | 0.40% |
| Sio Capital Management, LLC | 906,445 | $952,000 | 0.36% |
| AIGH Capital Management LLC | 1,027,585 | $1,079,000 | 0.28% |
| Greenlight Capital | 2,727,027 | $2,863,000 | 0.22% |
| Worth Venture Partners, LLC | 256,553 | $249,000 | 0.15% |
| PERKINS CAPITAL MANAGEMENT INC | 81,500 | $86,000 | 0.09% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $327,000 | 0.01% |